FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/31/2025
Back to search
Official data from USPTO
TRINCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
TRINCE
ST13
US500000079366929Class
5, 9, 10, 37, 41, 42
Filing
79366929
Registration
7592335
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 9, 10, 37, 41, 42
Filing date
02/14/2023
Registration date
12/10/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/10/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
BE
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Trince, besloten vennootschap
Representatives
Clifford D Hyra Fresh IP PLC
Technical classification
Nice Classes
Class 5Class 9Class 10Class 37Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells for medical or clinical use; personalized autologous or allogeneic cell-based therapies in the nature of cells for medical use; biological preparations for use in cell cultures for medical applications; pharmaceutical preparations and substances for the treatment of genetic diseases in the nature of single-gene disordersimmunological diseases and cancer; pharmaceutical preparations and substances for applications in tissue engineering and regenerative medicine for cell transplantationstem cell therapy and gene therapy; reagents for medical use; biological reagents for medical use; diagnostic reagents for medical use; reagents for use in medical genetic testing; stem cells for medical purposes; engineered medicinal cell-based productscell lines and biomoleculesgenetically engineered cells for medical use; medical reagents contained in a cartridge for medical diagnostic use
Class 9
Scientific apparatus and instruments for cell modificationtransfection devices; scientific apparatus and instruments for scientific research and developmenttransfection devices for cell modification; scientific apparatus and instruments for scientific research and developmentdevices for transfection of cells for clinical research and medical research; Scientific apparatus and instruments for use in cell therapystem cell therapytissue engineering and regenerative medicinedevices for the ablation and killing of cells; laboratory instruments for use in immunotherapy and cancer treatmenttransfection devices; laboratory instruments for use in tissue engineering and regenerative medicinedevices for transfectioncell and tissue ablation and cell killing; laboratory instruments for the development of gene modified cell therapiestransfection devices; laboratory equipment for modification of cells for research related to the treatment of diseasesdevices for transfectioncell ablation and cell killing; equipment for cell manipulationdevices for transfectioncell ablation and cell killing
Class 10
Medical devicestransfection devices used for cell therapy treatments; Medical devicesinstruments used for immunotherapy treatments and for modifying cells for the treatment of cancer and other diseases and medical conditions related to tissue engineering and regenerative medicine namelydevices for transfectioncell ablation and cell killing; apparatus for the regeneration of stem cells and tissues for medical purpose; medical apparatus and instruments for use in cell therapystem cell therapytissue engineering and regenerative medicinedevices for transfectioncell ablation and cell killing; unfilled cartridges for cell transfectioncell ablation and cell killing for medical diagnostic purposes
Class 37
Installationmaintenancerepair of medical apparatus and instruments; installationmaintenance and repair of laboratory apparatus and instruments; installationmaintenancerepair of scientific apparatus and instruments for scientific research and development in the field of cell modificationcell therapiesstem cell therapytissue engineering and regenerative medicine; provision of information relating to the installationmaintenancerepair of medical apparatus and instrumentslaboratory apparatus and instrumentsscientific apparatus and instruments for scientific research and development in the field of cell modificationcell therapiesstem cell therapytissue engineering and regenerative medicine
Class 41
Educational servicesconducting classesseminarscourses and workshops in the medicalpharmaceutical and scientific fields; educational services in the field of genetic medicine and therapiescell therapies and gene-modified cell therapies rendered through face-to-face and web-based coursesseminarsworkshops and training sessions; training services in the medicalpharmaceutical and scientific fields; Training in the use and operation of scientific apparatus for cell modification and scientific apparatus and instruments for scientific research and development; organization and conducting of workshops in the medicalpharmaceutical and scientific fields; publication of books in the medicalpharmaceutical and scientific fields; providing online non-downloadable electronic publications in the nature of booksmagazinesjournalsarticles and manuals featuring information relating to the medicalpharmaceutical and scientific fields
Class 42
Scientific research and consultation services in the field of cell modification; research and development services in the field of cell therapies; biological and medical research and consultation services related thereto in the field of cell modification; product research and development in the fields of biology and medical sciences; providing laboratory research services in the field of gene expression; providing medical research information in the field of cancer and cell therapy related thereto; medical and scientific research services related to the use of human stem cells for therapeutic purposes; Scientific research services for others in the fields of oncologyimmunotherapy treatmentstissue engineeringregenerative medicine and biological cell modification procedures; medical laboratory services; development of cell therapies using genetic cell modification technology; development of gene modified cell therapies; research and development in the pharmaceutical and biotechnology fields; laboratory analysis and industrial research services in the medicalbiotechnologicalnanomaterials and pharmaceutical fields
Publications
History of USPTO decisions and trademark events.
38 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/09/2025
FIMP
FINAL DISPOSITION PROCESSED
05/09/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/08/2024
PUBO
PUBLISHED FOR OPPOSITION
10/08/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/18/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/03/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/03/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/01/2024
GNFR
FINAL REFUSAL E-MAILED
05/01/2024
CNFR
FINAL REFUSAL WRITTEN
05/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/21/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/21/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/21/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/21/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/21/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/21/2023
RFNT
REFUSAL PROCESSED BY IB
12/12/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/22/2023
RFRR
REFUSAL PROCESSED BY MPU
11/22/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/21/2023
CNRT
NON-FINAL ACTION WRITTEN
11/20/2023
DOCK
ASSIGNED TO EXAMINER
11/14/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/04/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/06/2023
Continuous trademark protection
Get notified about every new filing that threatens TRINCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.